Abstract
The Psychobiological Model of Temperament and Character (also known as the Seven Factor model) is described in detail in this review, in terms of its neurophysiological underpinnings, psychometric properties, and clinical applications in the diagnosis and treatment planning of personality disorder (PD). The Temperament and Character Inventory (TCI), a self-report test developed to assess temperament and character traits, is used to evaluate bio-genetic (temperament) and adaptive (character) aspects of personality. Diagnosis of PD is a 2-step process that involves both character assessment (character is essential to assess mal-adaptation, as the core impairment shared by all subtypes of PD) and temperament assessment (temperament is used to distinguish specific symptomatic presentations in differential diagnosis of PD). We advocate that the Seven Factor Model of Temperament and Character provides a theoretical framework for more productive research, assessment, and treatment of normal personality and PD. In addition, pharmacotherapy and psychotherapy of PD are discussed in some detail, including pharmacological management of temperament and psychotherapy of character based on TCI scores. Finally, congruence between the Seven Factor model and the expected DSM-5 classification of and approach to PD are discussed in some detail.
Keywords: Personality, personality disorder, pharmacotherapy, diagnosis, temperament, character, DSM-5, Psychobiological, Dysregulation, diagnosing maladaptation, narcissistic, egosyntonic, agoraphobia, paranoid, vascular dementia
Current Psychopharmacology
Title: Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5
Volume: 1
Author(s): Dragan M. Svrakic and C. Robert Cloninger
Affiliation:
Keywords: Personality, personality disorder, pharmacotherapy, diagnosis, temperament, character, DSM-5, Psychobiological, Dysregulation, diagnosing maladaptation, narcissistic, egosyntonic, agoraphobia, paranoid, vascular dementia
Abstract: The Psychobiological Model of Temperament and Character (also known as the Seven Factor model) is described in detail in this review, in terms of its neurophysiological underpinnings, psychometric properties, and clinical applications in the diagnosis and treatment planning of personality disorder (PD). The Temperament and Character Inventory (TCI), a self-report test developed to assess temperament and character traits, is used to evaluate bio-genetic (temperament) and adaptive (character) aspects of personality. Diagnosis of PD is a 2-step process that involves both character assessment (character is essential to assess mal-adaptation, as the core impairment shared by all subtypes of PD) and temperament assessment (temperament is used to distinguish specific symptomatic presentations in differential diagnosis of PD). We advocate that the Seven Factor Model of Temperament and Character provides a theoretical framework for more productive research, assessment, and treatment of normal personality and PD. In addition, pharmacotherapy and psychotherapy of PD are discussed in some detail, including pharmacological management of temperament and psychotherapy of character based on TCI scores. Finally, congruence between the Seven Factor model and the expected DSM-5 classification of and approach to PD are discussed in some detail.
Export Options
About this article
Cite this article as:
M. Svrakic Dragan and Robert Cloninger C., Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5, Current Psychopharmacology 2012; 1 (2) . https://dx.doi.org/10.2174/2211556011201020122
DOI https://dx.doi.org/10.2174/2211556011201020122 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Neuromodulation for the treatment of psychiatric disorders
Neuromodulation techniques, including transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), magnetic seizure therapy (MST), electroconvulsive therapy (ECT), theta burst stimulation (TBS), vagus nerve stimulation (VNS), and deep brain stimulation (DBS), have been widely employed in the therapeutic management of prevalent psychiatric conditions such ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
High Throughput Screening Methodologies Classified for Major Drug Target Classes According to Target Signaling Pathways
Combinatorial Chemistry & High Throughput Screening Peptide Shuttle-Mediated Delivery for Brain Gene Therapies
Current Topics in Medicinal Chemistry A Review of the Pharmacological Properties of 3,4-dihydro-2(1H)- quinolinones
Mini-Reviews in Medicinal Chemistry CRISPR/Cas9 in Stem Cell Research: Current Application and Future Perspective
Current Stem Cell Research & Therapy Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher’s Disease
Current Medicinal Chemistry Unique Challenges of Type 1 Diabetes in the Preschool Population
Current Diabetes Reviews Editorial [Hot topic: Chemical Agents Positively and Negatively Affecting the Central Nervous System (Guest Editors: Abel Santamaria & Mauricio Diaz-Munoz)]
Central Nervous System Agents in Medicinal Chemistry Recent Advances in Epilepsy
Current Neuropharmacology Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas
Current Pharmaceutical Design Mechanisms Involved in Neuroprotective Effects of Transcranial Magnetic Stimulation
CNS & Neurological Disorders - Drug Targets Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Prodrug Strategies in the CNS Drugs: Small Modification Makes Big Improvements
Current Topics in Medicinal Chemistry Opioid Transport by ATP-Binding Cassette Transporters at the Blood-Brain Barrier: Implications for Neuropsychopharmacology
Current Pharmaceutical Design Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design Thymoquinone: Major Molecular Targets, Prominent Pharmacological Actions and Drug Delivery Concerns
Current Bioactive Compounds Takotsubo Cardiomyopathy: What we have Learned in the Last 25 Years? (A Comparative Literature Review)
Current Cardiology Reviews Carbon-11 Labeled Tracers for In Vivo Imaging of P-Glycoprotein Function: Kinetics, Advantages and Disadvantages
Current Topics in Medicinal Chemistry Unexpected Effects of Acetylcholine Precursors on Pilocarpine Seizure- Induced Neuronal Death
Current Neuropharmacology Bacopa monnieri Supplements Offset Paraquat-Induced Behavioral Phenotype and Brain Oxidative Pathways in Mice
Central Nervous System Agents in Medicinal Chemistry Inflammation in Neurodegenerative Disorders: Friend or Foe?
Current Aging Science